Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
BDRX
Stock Latest News
Company Announcements
Biodexa Pharmaceuticals Announces Successful AGM Resolutions
10d ago
6K
BDRX
Premium
The Fly
Biodexa announces activation of first clinical study site for Serenta trial
12d ago
BDRX
Premium
The Fly
Biodexa Pharmaceuticals unveils ‘Serenta’ as name for upcoming Phase 3 FAP study
14d ago
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Announces Successful Passing of General Meeting Resolutions
26d ago
6K
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Initiates Phase 2 Study for Type 1 Diabetes Treatment
1M ago
6K
BDRX
Premium
The Fly
Biodexa announces recruitment of first patient in Phase 2 tolimidone study
1M ago
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Provides Shareholder Update and Advances eRapa Phase 3 Program
1M ago
6K
BDRX
Premium
The Fly
Biodexa Pharmaceuticals sees cash runway into 1Q26
1M ago
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Releases 2024 Annual Report and Announces AGM
1M ago
6K
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Plans Share Capital Reorganization and New Share Allotment
2M ago
6K
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Secures Additional $3M Grant for eRapa Phase 3 Program
2M ago
6K
BDRX
Premium
The Fly
Biodexa Pharmaceuticals announces award of additional $3M grant from CPRIT
2M ago
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Lowers Warrant Exercise Price to Boost Capital
2M ago
6K
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Secures EU Orphan Drug Designation for eRapa in FAP
2M ago
6K
BDRX
Premium
The Fly
Biodexa Pharmaceuticals receives orphan drug designation in Europe for eRapa
2M ago
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Faces Setback as Key Resolution Fails at General Meeting
2M ago
6K
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Announces General Meeting for Strategic Share Resolutions
3M ago
6K
BDRX
Premium
Company Announcements
Biodexa Pharmaceuticals Reports 2024 Preliminary Results and 2025 Strategic Priorities
3M ago
6K
BDRX
Premium
The Fly
Biodexa reports preliminary FY24 EPS GBP (0.1)p vs GBP (2)p last year
3M ago
BDRX
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
IBO
LLY
Premium
Market News
3 Penny Stocks to Watch Now, 3/20/25
4M ago
ATER
BDRX
Premium
The Fly
Biodexa says on track to initiate Phase 3 trial in FAP next quarter
4M ago
BDRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
